CHIME
Cerebral HemodynamIcs, Metabolism and clearancE: A comprehensive, non-invasive brain imaging approach to characterize key biological processes in dementia.
MRI for fingerprinting dementia uitklapper, klik om te openen
There are 55 million people worldwide with dementia, a brain disorder that can be caused by a variety of diseases and is still incurable. The underlying disease processes often begin decades before the first symptoms of dementia appear. The CHIME consortium aims to find clues in these early disease processes for timely diagnosis and treatment. To achieve this, the researchers are developing MRI-based technologies that visualise three important interrelated processes: changes in blood flow, metabolic processes and the removal of waste materials. In this way, they hope to find biomarkers that will improve both the development of new drugs and the diagnosis, prognosis and monitoring of dementia patients.
News uitklapper, klik om te openen
Meet the PhD-student — Simone van der Schot
Read more
CHIME user meeting at Philips: a collaborative step forward
Read more
Meet the PhD-student — Maaike van Tol
Read more
Meet the PhD-student — Konstantinos Olympios
Read more
CHIME Project Partners Meet in Leiden for Second Meeting
Read more
A New Step in Dementia Research
Read more
Overview news items
Project leader
Dr. Jaco J.M. Zwanenburg (UMC Utrecht)
Budget (incl. co-financing)
€4,5 million
Academic Centers
Erasmus Medical Centre, Leiden University Medical Center, University Medical Center Utrecht
Companies
Merck & Co., Inc., Philips Medical Systems B.V., Pie Medical Imaging, WaveTronica
Stakeholders
